ATE80801T1 - Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln. - Google Patents

Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln.

Info

Publication number
ATE80801T1
ATE80801T1 AT86900504T AT86900504T ATE80801T1 AT E80801 T1 ATE80801 T1 AT E80801T1 AT 86900504 T AT86900504 T AT 86900504T AT 86900504 T AT86900504 T AT 86900504T AT E80801 T1 ATE80801 T1 AT E80801T1
Authority
AT
Austria
Prior art keywords
reaction product
pharmaceutically acceptable
antitumors
penicillamin
pharmaceuticals
Prior art date
Application number
AT86900504T
Other languages
English (en)
Inventor
David Rubin
Original Assignee
Clark Pharma Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clark Pharma Dev filed Critical Clark Pharma Dev
Application granted granted Critical
Publication of ATE80801T1 publication Critical patent/ATE80801T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT86900504T 1984-12-18 1985-12-16 Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln. ATE80801T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68299184A 1984-12-18 1984-12-18
EP86900504A EP0226591B1 (de) 1984-12-18 1985-12-16 Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln
PCT/US1985/002480 WO1986003677A1 (en) 1984-12-18 1985-12-16 Anti-tumor compositions containing the reaction product of a cytotoxic aldehyde with penicillamine and method of use thereof

Publications (1)

Publication Number Publication Date
ATE80801T1 true ATE80801T1 (de) 1992-10-15

Family

ID=24742098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86900504T ATE80801T1 (de) 1984-12-18 1985-12-16 Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln.

Country Status (9)

Country Link
US (1) US5169858A (de)
EP (1) EP0226591B1 (de)
JP (1) JPS62501769A (de)
AT (1) ATE80801T1 (de)
AU (1) AU642393B2 (de)
CA (1) CA1303505C (de)
DE (1) DE3586683T2 (de)
WO (1) WO1986003677A1 (de)
ZA (1) ZA864961B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476842A (en) * 1991-11-04 1995-12-19 Co Enzyme Technology Ltd. Method and compositions for treating tumors having high tyrosinase activity
US5760008A (en) * 1991-11-04 1998-06-02 Co Enzyme Technology Ltd. Method and compositions for treating malignant tumors and inhibiting metastases of malignant tumors
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US6703050B1 (en) 1998-09-04 2004-03-09 The Regents Of The University Of Michigan Methods and compositions for the prevention or treatment of cancer
EP1143951A3 (de) * 1998-09-21 2002-02-06 University Of Florida Research Foundation, Inc. Mittel gegen malaria
US20070248689A1 (en) * 2002-05-24 2007-10-25 Regents Of The University Of Michigan Copper lowering treatment of inflammatory and fibrotic diseases
WO2003099223A2 (en) * 2002-05-24 2003-12-04 The Regents Of The University Of Michigan Copper lowering treatment of inflammatory and fibrotic diseases
JP2005538093A (ja) 2002-07-23 2005-12-15 ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン 抗血管形成療法のための、テトラポリアンモニウムテトラチオモリブデートおよび関連化合物
AU2003270473A1 (en) * 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
MX2007012226A (es) 2005-04-04 2007-12-10 Univ Florida Analogos de polieter de desferritiocina.
WO2008115433A1 (en) * 2007-03-15 2008-09-25 University Of Florida Desferrithiocin polyether analogues
BR112014014544A2 (pt) 2011-12-16 2017-06-13 Univ Florida usos de análogos de 4'-desferritiocina
KR20160003652A (ko) 2013-03-15 2016-01-11 캔써 리써치 테크놀로지, 엘엘씨 감마―글루타밀 주기 조절 방법 및 조성물
US10570104B2 (en) 2015-04-27 2020-02-25 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384001A (en) * 1978-12-21 1983-05-17 Gosalvez Mario Treatment of tumors with thiazolidine-4-carboxylic acid
JPS55167220A (en) * 1979-06-14 1980-12-26 Senjiyu Seiyaku Kk Antitumor drug
JPS5633216A (en) * 1979-08-29 1981-04-03 Shimadzu Corp Cutting method and cutter for dynamic balancing correction device
JPS57128625A (en) * 1981-01-30 1982-08-10 Rikagaku Kenkyusho Carcinostatic

Also Published As

Publication number Publication date
EP0226591B1 (de) 1992-09-23
ZA864961B (en) 1987-02-25
US5169858A (en) 1992-12-08
AU5972686A (en) 1988-01-07
CA1303505C (en) 1992-06-16
DE3586683D1 (de) 1992-10-29
DE3586683T2 (de) 1993-04-08
WO1986003677A1 (en) 1986-07-03
JPS62501769A (ja) 1987-07-16
EP0226591A1 (de) 1987-07-01
EP0226591A4 (de) 1987-06-01
AU642393B2 (en) 1993-10-21

Similar Documents

Publication Publication Date Title
ATE80801T1 (de) Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln.
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE84414T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
ATA249588A (de) 4h-1-benzopyran-4-on-derivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische zusammensetzung, welche dieselben als wirkstoff enthalten
JPS6485984A (en) Methylenephosphonoalkylphosphinates, medicinal composition and therapy for abnormal calcium and phosphate metabolism
ATE270553T1 (de) Anwendung von 1,2,4-benzotriazinoxiden zur herstellung eines arzneimittels zur behandlung von tumoren
OA06930A (fr) Procédé de préparation d'acides aza-bicyclo-octane carboxyliques.
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
FR2497196B1 (fr) Procede de preparation d'esters d'acides carboxyliques
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
EP0210351A3 (en) Use of porphyrin derivatives in the detection and treatment of tumours
DE3248943D2 (en) Method for the diagnostic and the therapeutic treatment of tumors and/or infectious diseases of all sorts by the use of alkaloid compositions or the salts thereof
EP0286928A3 (de) Neue 2-Acylpyrrolidin-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel sowie deren Verwendung
ATE2423T1 (de) 1-acyloxyphenyl-1,2-diphenylalken-derivate, verfahren zu deren herstellung und eine diese derivate enthaltende pharmazeutische zusammensetzung.
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
JPS5728031A (en) Ethylenediamine derivative and medicinal composition as effective component thereof
ZA814430B (en) Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
JPS56128714A (en) Oral absorption-improved beta-lactam antibiotic oral dosage
GB2157283B (en) Esters of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
PT78939B (en) Process for preparing esters of pantetheine and pantethine with 3-pyridineacetic or 3-(3-pyridylmethoxycarbonyl)-propionic acid and of pharmaceutical compositions containing the same
ATE42101T1 (de) Omega-aryl-alkylthienyl-verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
ES8200363A1 (es) Procedimiento para la obtencion de esteres 4,5-dialquil-3- hidroxi-pirrol-2-carboxilicos
DE3476520D1 (en) Use of a mixture of compounds for the manufacture of a composition for the treatment of buerger's disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties